Infectious Diseases – News and Features

Lumora has secured £1.5 million from the completion of the company’s latest funding round, led by Catapult Venture Managers Ltd.

Proteros will apply its know-how, experience of structural analysis and proprietary X-ray crystallography platform to support IP-K’s mission to develop therapeutics for infectious diseases.

This article details how researchers from the Bavarian Health and Food Safety Authority have set up a rapid and reliable high-throughput multiplex one-step real-time RT-PCR for the surveillance of influenza.

The acquisition of Myconostica expands Lab21’s growing proprietary diagnostic portfolio and will provide the Company’s first set of nucleic acid-based assays.

This paper, published in the journal CrystEngComm, describes how researchers have modified the hydrogen bonding in isonicotinic acid hydrazide (isoniazid) in order to control the self-assembly process.

Mr. Huebner currently serves as Managing Director at LynxCom Partners, LLC - a Healthcare Consulting Firm.

Benitec has received rights issue acceptances for 302,716,126 shares, with the shortfall applications from existing shareholders.

Trial receives positive review from Independent Data Monitoring Committee.

CD-Venture joins strong syndicate of existing VC investors.

Patent claims provide protection for next generation PMO chemistry, extending AVI leadership.